KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 156 filers reported holding KURA ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,467,982 | -51.8% | 160,963 | -44.1% | 0.00% | – |
| Q2 2023 | $3,044,151 | +17.9% | 287,727 | +36.3% | 0.00% | – |
| Q1 2023 | $2,581,093 | -24.6% | 211,046 | -23.5% | 0.00% | – |
| Q4 2022 | $3,422,578 | -35.8% | 275,792 | -29.4% | 0.00% | -100.0% |
| Q3 2022 | $5,334,000 | -58.2% | 390,508 | -43.9% | 0.00% | -50.0% |
| Q2 2022 | $12,753,000 | +78.3% | 695,800 | +56.4% | 0.00% | +100.0% |
| Q1 2022 | $7,154,000 | +514.1% | 444,840 | +434.1% | 0.00% | – |
| Q4 2021 | $1,165,000 | -61.4% | 83,289 | -48.3% | 0.00% | – |
| Q3 2021 | $3,015,000 | -20.3% | 161,027 | -11.3% | 0.00% | – |
| Q2 2021 | $3,785,000 | +691.8% | 181,511 | +973.9% | 0.00% | – |
| Q1 2021 | $478,000 | -76.9% | 16,902 | -73.3% | 0.00% | – |
| Q4 2020 | $2,065,000 | +305.7% | 63,240 | +280.2% | 0.00% | – |
| Q3 2020 | $509,000 | +32.6% | 16,633 | -29.4% | 0.00% | – |
| Q2 2020 | $384,000 | +163.0% | 23,558 | +60.4% | 0.00% | – |
| Q1 2020 | $146,000 | -84.6% | 14,684 | -78.7% | 0.00% | – |
| Q4 2019 | $949,000 | +124.3% | 69,081 | +148.3% | 0.00% | – |
| Q3 2019 | $423,000 | -13.8% | 27,820 | +11.6% | 0.00% | – |
| Q2 2019 | $491,000 | +46.1% | 24,928 | +23.2% | 0.00% | – |
| Q1 2019 | $336,000 | -60.3% | 20,240 | -66.5% | 0.00% | – |
| Q4 2018 | $846,000 | -12.1% | 60,328 | +9.7% | 0.00% | – |
| Q3 2018 | $963,000 | -34.0% | 55,014 | -31.4% | 0.00% | – |
| Q2 2018 | $1,460,000 | +27.5% | 80,211 | +31.5% | 0.00% | – |
| Q1 2018 | $1,145,000 | -68.7% | 61,000 | -74.5% | 0.00% | -100.0% |
| Q4 2017 | $3,663,000 | +548.3% | 239,382 | +534.0% | 0.00% | – |
| Q3 2017 | $565,000 | -89.4% | 37,756 | -93.4% | 0.00% | -100.0% |
| Q2 2017 | $5,321,000 | -29.8% | 572,223 | -33.5% | 0.00% | +100.0% |
| Q1 2017 | $7,576,000 | +310.8% | 860,856 | +175.5% | 0.00% | – |
| Q4 2016 | $1,844,000 | +4188.4% | 312,524 | +4435.9% | 0.00% | – |
| Q3 2016 | $43,000 | +975.0% | 6,890 | +330.6% | 0.00% | – |
| Q2 2016 | $4,000 | – | 1,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |